TABLE 5.
The 10-year late side-events occurred in our patient cohorts.
| 10-year prevalence of late side-effects (n = 55) | ||||
| Toxicity (n) | Grade 1 | Grade 2 | Grade 3 | Grade 4 |
| Hyperpigmentation | 1 | 0 | 0 | 0 |
| Atrophy | 1 | 0 | 0 | 0 |
| Alopecia | 1 | 0 | 0 | 0 |
| Lung function | 1 | 0 | 0 | 0 |
The 10-year late side-events occurred in our patient cohorts.
| 10-year prevalence of late side-effects (n = 55) | ||||
| Toxicity (n) | Grade 1 | Grade 2 | Grade 3 | Grade 4 |
| Hyperpigmentation | 1 | 0 | 0 | 0 |
| Atrophy | 1 | 0 | 0 | 0 |
| Alopecia | 1 | 0 | 0 | 0 |
| Lung function | 1 | 0 | 0 | 0 |